sb 203580 has been researched along with gamma-aminobutyric acid in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (gamma-aminobutyric acid) | Trials (gamma-aminobutyric acid) | Recent Studies (post-2010) (gamma-aminobutyric acid) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 40,215 | 1,423 | 9,631 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikami, M; Takahashi, A; Yang, J | 1 |
1 other study(ies) available for sb 203580 and gamma-aminobutyric acid
| Article | Year |
|---|---|
p38 mitogen-activated protein kinase independent SB203580 block of H2O2-induced increase in GABAergic mIPSC amplitude.
Topics: Animals; Drug Interactions; Enzyme Inhibitors; gamma-Aminobutyric Acid; Glutathione; Hydrogen Peroxide; Imidazoles; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Mice; Mice, Inbred C57BL; Neurons; Oxidants; p38 Mitogen-Activated Protein Kinases; Phosphopyruvate Hydratase; Pyridines; Spinal Cord | 2007 |